111
10. Momparler, RL, Bovenzi, V. DNA methylation and cancer. J. Cell
Physiol. 183, 145-154 (2000).
11. Dueñas-Gonzáles, A, Lizano, M, Candelaria, M, Cetina, L, Arce, C,
Cervera, E. Epigenetic of cervical câncer. Na overview and therapeutic
perspectives. Molecular Câncer 4, 38-61 (2005).
12. Herman, JC, Merlo, A, Mão, L, Lapidus, RG, Issa, JP, Davidson, NE,
Sidransky, D, Baylin, SB. Inactivation of the CDKN2/p16/MST1 gene is
frequently associated with aberrant DNA methylation in all common
human cancers. Cancer Research 55, 4525-30 (1995).
13. Kim, NR, Lin, Z, Kim, KR, Cho, HY, Kim, I. Epstein-Barr virus an
p16INK4A methylation in squamous cell carcinoma anp precancerous
lesions of the cervix uteri. Journal of Korean Medical Science 20, 636-42
(2005).
14. Chen, CH, Wang, WJ, Kuo, JC, Tsai, HC, Lin, JR, Chang, ZF, Chen, RH.
Bidirectional signal transduced by DAPK-ERK ineraction promote the
apoptotic effect of DAPK. The EMBO Journal 24, 294-304 (2005).
15. Christoph, F, Hinz, S, Kempkensteffen, C, Weikert, S, Krause, H,
Schostak, M, Schrader, M, Miller, K. A gene expression profile of tumor
suppressor genes commoly methylated in bladder cancer. Journal of
Cancer Reearch and Clinical Oncology 133, 343-349 (2007).
16. Christoph, F, Hinz, S, Kempkensteffen, C, Schostak, M, Schrader, M,
Miller, K. mRNA espression profiles of methylated APAF-1 and DAPK-1
tumor suppressor genes uncover clear cell renal carcinomas with
aggressive phenotype. The Journal of Urology 178, 2655-2659 (2007).